<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04803500</url>
  </required_header>
  <id_info>
    <org_study_id>PER 15-1M</org_study_id>
    <nct_id>NCT04803500</nct_id>
  </id_info>
  <brief_title>Simvastatin Around Immediate Implant</brief_title>
  <official_title>Restoration of Immediate Peri-implant Defect by Simvastatin: a Controlled Clinical and Cone Beam Computed Tomography Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study evaluated the effect of local application of simvastatin around immediate implant&#xD;
      on the amount of gap fill, ridge dimensional alterations and bone density in humans.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2, 2015</start_date>
  <completion_date type="Actual">May 3, 2016</completion_date>
  <primary_completion_date type="Actual">February 15, 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Split-mouth design</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of simvastatin on gap fill</measure>
    <time_frame>3 months after implant placement</time_frame>
    <description>using cone beam computed tomography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of simvastatin on horizontal ridge dimension</measure>
    <time_frame>3 months after implant placement</time_frame>
    <description>using cone beam computed tomography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of simvastatin on crestal bone level</measure>
    <time_frame>3 months after implant placement</time_frame>
    <description>using cone beam computed tomography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of simvastatin on bone density</measure>
    <time_frame>3 months after implant placement</time_frame>
    <description>using cone beam computed tomography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of wound healing</measure>
    <time_frame>1 week after implant placement</time_frame>
    <description>wound healing index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of wound healing</measure>
    <time_frame>2 weeks after implant placement</time_frame>
    <description>wound healing index</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Immediate Implant Placement</condition>
  <condition>Bone Regeneration</condition>
  <condition>Alveolar Bone Resorption</condition>
  <arm_group>
    <arm_group_label>Simvastatin group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>simvastatin gel (1.2 mg/0.1 ml of solid lipid nanoparticles) was locally applied to fill the jumping distance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>the solid lipid nanoparticles carrier was injected into the jumping distance.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Simvastatin</intervention_name>
    <description>single injection of simvastatin gel in the gap around immediately placed implant</description>
    <arm_group_label>Simvastatin group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>single injection of the solid lipid nanoparticle carrier in the gap around immediately placed implant</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients between 20 and 50 years old&#xD;
&#xD;
          -  requiring the extraction of 2 non-restorable maxillary canine or premolar on each side&#xD;
             of the arch&#xD;
&#xD;
          -  following extraction, the crestal bone had to be located 3 mm apical to the free&#xD;
             gingival margin&#xD;
&#xD;
          -  at least 3 mm of bone beyond the root apex was required to guarantee implant primary&#xD;
             stability&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  unstable systemic diseases precluding surgical procedures&#xD;
&#xD;
          -  compromised general health conditions that would impair bone healing including present&#xD;
             history of bone irradiation, patient on bisphosphonates therapy, antitumor&#xD;
             chemotherapy&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  compromised healing conditions e.g. uncontrolled diabetes mellitus&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>February 7, 2021</study_first_submitted>
  <study_first_submitted_qc>March 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 17, 2021</study_first_posted>
  <last_update_submitted>March 16, 2021</last_update_submitted>
  <last_update_submitted_qc>March 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Mina Adel Rizk Botros</investigator_full_name>
    <investigator_title>Assistant Researcher</investigator_title>
  </responsible_party>
  <keyword>Simvastatin</keyword>
  <keyword>Immediate implant placement</keyword>
  <keyword>gap distance</keyword>
  <keyword>ridge dimension alteration</keyword>
  <keyword>cone beam computed tomopgraphy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bone Resorption</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Simvastatin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

